We are live on
!
Find out more
HA
Havens Advisors Portfolio holdings
AUM
$39.3M
1-Year Est. Return
80.07%
This Fund
S&P 500
This Quarter
Est. Return
+20.16%
1 Year Est. Return
+80.07%
3 Year Est. Return
+460.15%
5 Year Est. Return
+1,430.14%
10 Year Est. Return
–
AUM
$39.3M
AUM Growth
-$27.5M
(-41%)
Cap. Flow
-$27.5M
Cap. Flow
% of AUM
-69.86%
Top 10 Holdings %
Top 10 Hldgs %
61.25%
Holding
55
New
14
Increased
5
Reduced
6
Closed
24
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Rentokil
RTO
|
+$2.51M |
| 2 |
SWIR
Sierra Wireless
SWIR
|
+$2.15M |
| 3 |
First Horizon
FHN
|
+$1.99M |
| 4 |
POSH
Poshmark, Inc. Class A Common Stock
POSH
|
+$1.94M |
| 5 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$1.74M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CCXI
ChemoCentryx, Inc.
CCXI
|
+$3.88M |
| 2 |
TMX
Terminix Global Holdings, Inc.
TMX
|
+$3.8M |
| 3 |
Y
Alleghany Corp
Y
|
+$3.69M |
| 4 |
NLSN
Nielsen Holdings plc
NLSN
|
+$3.5M |
| 5 |
GBT
Global Blood Therapeutics, Inc.
GBT
|
+$3.13M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.28% |
| 2 | Financials | 17.89% |
| 3 | Healthcare | 12.57% |
| 4 | Industrials | 12.52% |
| 5 | Consumer Discretionary | 7.2% |
Similar funds
JI
BGP
NRC
EOCM
LN
ACM
CL
ECM
Havens Advisors's Q4 2022 Portfolio in Review
As of Q4 2022, Havens Advisors held 55 positions worth $39.3M, down 41% from $66.8M the previous quarter. Its ten largest holdings account for 61% of the portfolio.
Havens Advisors withdrew a net $27.5M in Q4 2022, closing 24 positions and reducing 6 holdings. Its most notable exit was ChemoCentryx, Inc., an estimated $3.88M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 34% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Havens Advisors opened a new position in Rentokil worth $2.5M.
- Havens Advisors's largest Q4 2022 buy was Rentokil: 81,000 shares worth $2.5M.
- Havens Advisors added most to First Horizon in Q4 2022, an estimated $1.99M increase.
- Havens Advisors's biggest Q4 2022 reduction was Rogers Corp, cutting an estimated $2.02M.
- Havens Advisors fully exited ChemoCentryx, Inc. in Q4 2022, selling an estimated $3.88M.
- Havens Advisors's ten largest holdings make up 61% of its $39.3M portfolio in Q4 2022.
- Havens Advisors opened 14 new positions and closed 24 in Q4 2022.
- Havens Advisors's portfolio value fell 41% quarter-over-quarter to $39.3M.
Based on Havens Advisors's 13F filing for Q4 2022, filed 25 Jan 2023.